MY194060A - External preparation for skin for wrinkle improvement - Google Patents

External preparation for skin for wrinkle improvement

Info

Publication number
MY194060A
MY194060A MYPI2021005518A MYPI2021005518A MY194060A MY 194060 A MY194060 A MY 194060A MY PI2021005518 A MYPI2021005518 A MY PI2021005518A MY PI2021005518 A MYPI2021005518 A MY PI2021005518A MY 194060 A MY194060 A MY 194060A
Authority
MY
Malaysia
Prior art keywords
skin
linear
branched alkyl
alkyl group
compound
Prior art date
Application number
MYPI2021005518A
Other languages
English (en)
Inventor
Shigetsugu Homma
Toshihiro Hinokitani
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of MY194060A publication Critical patent/MY194060A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI2021005518A 2016-06-24 2017-06-21 External preparation for skin for wrinkle improvement MY194060A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016125685 2016-06-24

Publications (1)

Publication Number Publication Date
MY194060A true MY194060A (en) 2022-11-10

Family

ID=60783440

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI2021005518A MY194060A (en) 2016-06-24 2017-06-21 External preparation for skin for wrinkle improvement
MYPI2018002290A MY189548A (en) 2016-06-24 2017-06-21 External preparation for skin for wrinkle improvement

Family Applications After (1)

Application Number Title Priority Date Filing Date
MYPI2018002290A MY189548A (en) 2016-06-24 2017-06-21 External preparation for skin for wrinkle improvement

Country Status (17)

Country Link
US (1) US11413224B2 (enExample)
EP (2) EP4008304B1 (enExample)
JP (2) JP6554752B2 (enExample)
KR (1) KR102431188B1 (enExample)
CN (2) CN113693965B (enExample)
AU (1) AU2017282393B2 (enExample)
BR (1) BR112018073968B1 (enExample)
CA (1) CA3026270C (enExample)
ES (1) ES2905761T3 (enExample)
IL (2) IL263275B (enExample)
MX (1) MX384082B (enExample)
MY (2) MY194060A (enExample)
RU (1) RU2743039C2 (enExample)
SG (1) SG11201810731WA (enExample)
TW (2) TWI734647B (enExample)
UA (1) UA122923C2 (enExample)
WO (1) WO2017221973A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200368131A1 (en) * 2017-11-15 2020-11-26 Pola Chemical Industries, Inc. Oil-based composition
JP2019206485A (ja) * 2018-05-29 2019-12-05 ポーラ化成工業株式会社 シワ改善用組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242874A (en) 1963-10-25 1966-03-29 Fisher & Ludlow Ltd Conveyors for conveying goods
JPS492483B1 (enExample) 1969-01-28 1974-01-21
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
JP3492483B2 (ja) 1996-10-03 2004-02-03 株式会社資生堂 ゲル状皮膚外用剤
KR100207078B1 (ko) 1996-10-18 1999-07-15 윤종용 세탁기
FR2757380B1 (fr) 1996-12-24 1999-01-29 Oreal Composition de maquillage ou de soin, sans transfert, contenant un organopolysiloxane et une phase grasse
JP2002161051A (ja) 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
KR19990043352A (ko) 1997-11-29 1999-06-15 전주범 학습능률을 위한 모니터의 화면밝기 조정장치 및 그 방법
US6610748B1 (en) * 1998-02-24 2003-08-26 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
JP2001040263A (ja) 1999-07-29 2001-02-13 Pentel Corp 水性光沢インキ組成物
AU7453700A (en) 1999-10-12 2001-04-23 Fujisawa Pharmaceutical Co., Ltd. Remedies for intractable wound
KR20020058077A (ko) 1999-12-03 2002-07-12 우에노 도시오 1,3,4-옥사디아졸린-2-온 유도체 및 그 유도체를 유효성분으로 하는 약제
EP1136064A3 (en) * 2000-03-21 2001-10-17 Avon Products, Inc. Method for improving the apperance of skin and topical compositions for practicing the same
JP2002255847A (ja) 2001-02-26 2002-09-11 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む機能性食品および医薬品
JP2003300851A (ja) 2002-04-10 2003-10-21 Pola Chem Ind Inc フレグランス組成物
JP4336486B2 (ja) 2002-10-04 2009-09-30 一丸ファルコス株式会社 ヒアルロン酸産生促進剤
FR2856924B1 (fr) * 2003-07-02 2008-08-22 Oreal Composition cosmetique contenant un elastomere de silicone et un polymere silicone bloc
JP2005041795A (ja) * 2003-07-24 2005-02-17 P & P F:Kk 凹凸補正用油性化粧料
US20090011035A1 (en) * 2007-07-03 2009-01-08 Joseph Michael Zukowski Personal care composition
CN102215812B (zh) * 2008-11-19 2014-09-10 宝丽化成工业有限公司 抗皱剂
WO2012124436A1 (ja) * 2011-03-17 2012-09-20 株式会社 資生堂 皮膚化粧料
JP6536321B2 (ja) * 2014-10-01 2019-07-03 日油株式会社 オイルゲル化粧料

Also Published As

Publication number Publication date
CN109310585B (zh) 2021-10-29
JPWO2017221973A1 (ja) 2018-06-28
TWI720214B (zh) 2021-03-01
TW201803550A (zh) 2018-02-01
KR20190021216A (ko) 2019-03-05
BR112018073968A2 (pt) 2019-02-26
EP3476381B1 (en) 2021-12-22
JP2019048889A (ja) 2019-03-28
IL263275B (en) 2021-03-25
JP6554752B2 (ja) 2019-08-07
CN113693965A (zh) 2021-11-26
RU2018142778A (ru) 2020-07-24
SG11201810731WA (en) 2019-01-30
JP7016794B2 (ja) 2022-02-07
CA3026270A1 (en) 2017-12-28
RU2018142778A3 (enExample) 2020-10-13
UA122923C2 (uk) 2021-01-20
EP4008304A2 (en) 2022-06-08
KR102431188B1 (ko) 2022-08-10
AU2017282393A1 (en) 2018-12-13
IL263275A (en) 2018-12-31
BR112018073968B1 (pt) 2022-08-02
MX2018014932A (es) 2019-04-24
AU2017282393B2 (en) 2022-06-02
ES2905761T3 (es) 2022-04-12
US11413224B2 (en) 2022-08-16
CA3026270C (en) 2024-06-18
CN113693965B (zh) 2024-03-29
EP3476381A4 (en) 2020-01-01
EP4008304A3 (en) 2022-07-20
EP3476381A1 (en) 2019-05-01
MX384082B (es) 2025-03-14
WO2017221973A1 (ja) 2017-12-28
IL274153A (en) 2020-06-30
TW202110470A (zh) 2021-03-16
CN109310585A (zh) 2019-02-05
EP4008304B1 (en) 2025-07-23
MY189548A (en) 2022-02-16
RU2743039C2 (ru) 2021-02-12
TWI734647B (zh) 2021-07-21
US20210030631A1 (en) 2021-02-04
IL274153B (en) 2021-12-01

Similar Documents

Publication Publication Date Title
ZA202110659B (en) Methods of reducing the risk of cardiovascular events in a subject
TN2021000028A1 (en) Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject
WO2016077464A8 (en) Amino acid derivatives and their uses
EP4585270A3 (en) Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same
AU2015275248B2 (en) Legumain activated doxorubicin derivative as well as preparation method and application thereof
MX2015014746A (es) Derivados de dolastatina 10 y auristatinas.
PH12019502868A1 (en) Composition for injection
BR112016017747A2 (pt) Agente de intensificação de efeito de reabilitação pós lesão de nervo compreendendo derivados de éter de alquila ou sal do mesmo
AU2018274378A1 (en) Compound used as autophagy regulator, and preparation method therefor and uses thereof
BR112017023144A2 (pt) composições cosméticas compreendendo ésteres de estolídeo e usos para o tratamento capilar
MY195881A (en) Griseofulvin Compound
MX2013007938A (es) Compuesto biciclico novedoso o sal del mismo.
MX2017016120A (es) Agentes solubilizantes para compuestos activos funcionales.
MY189548A (en) External preparation for skin for wrinkle improvement
GEP20247683B (en) Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof
IN2015DN01329A (enExample)
WO2012142125A3 (en) Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
AU2014378413A1 (en) Emulsion composition for skin
BR112012020703A2 (pt) composição para o controle de pragas
GB2561645A8 (en) Cosmetic product to prevent body odor with an improved long-term effect
MY169329A (en) Derivative of butylphthalide and preparation method and use thereof
PH12015500047A1 (en) Pharmaceutical composition for inhibiting autophagy of motor neurons and use thereof
MX2019006939A (es) Preparacion liquida parenteral que comprende compuesto de carbamato.
RU2018108879A (ru) Активные композиции с высоким значением рн
PH12020550549A1 (en) Compositions for preventing or treating lupus